Is Now a Good Time to Buy Biogen Stock?

Biogen (NASDAQ: BIIB) faces continued challenges for several of its current products. However, the company also now has Alzheimer's disease drug Aduhelm, which could be a huge commercial success. In this Motley Fool Live video, recorded on July 19, 2021, healthcare and cannabis bureau chief Corinne Cardina and Motley Fool contributor Keith Speights answer a viewer's question about whether now is a good time to buy Biogen stock.

Continue reading

Source Fool.com